These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 28153820)

  • 1. First line dual therapy for gonorrhoea to limit the spread of antimicrobial resistance.
    Mohammed H; Sile B; Furegato M; Woodhall S; Fifer H; Hughes G
    BMJ; 2017 Feb; 356():j565. PubMed ID: 28153820
    [No Abstract]   [Full Text] [Related]  

  • 2. Will use of combination cephalosporin/azithromycin therapy forestall resistance to cephalosporins in Neisseria gonorrhoeae?
    Rice LB
    Sex Transm Infect; 2015 Jun; 91(4):238-40. PubMed ID: 25926405
    [No Abstract]   [Full Text] [Related]  

  • 3. The 2012 European guideline on the diagnosis and treatment of gonorrhoea in adults recommends dual antimicrobial therapy.
    Unemo M;
    Euro Surveill; 2012 Nov; 17(47):. PubMed ID: 23231859
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of gonococcal infection: when one drug is not enough.
    Kransdorf LN; Kling JM; Mayer AP
    J Womens Health (Larchmt); 2014 Jul; 23(7):627-8. PubMed ID: 24918549
    [No Abstract]   [Full Text] [Related]  

  • 5. Cost-Effectiveness of Dual Antimicrobial Therapy for Gonococcal Infections Among Men Who Have Sex With Men in the Netherlands.
    Xiridou M; Lugnér A; de Vries HJ; van Bergen JE; Götz HM; van Benthem BH; Wallinga J; van der Sande MA
    Sex Transm Dis; 2016 Sep; 43(9):542-8. PubMed ID: 27513379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Important treatment change for Neisseria gonorrhoea.
    McCarty EJ; Dinsmore WW
    J Forensic Leg Med; 2013 Apr; 20(3):181. PubMed ID: 23472801
    [No Abstract]   [Full Text] [Related]  

  • 7. Persistence of an outbreak of gonorrhoea with high-level resistance to azithromycin in England, November 2014‒May 2018.
    Smolarchuk C; Wensley A; Padfield S; Fifer H; Lee A; Hughes G
    Euro Surveill; 2018 Jun; 23(23):. PubMed ID: 29897041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends in antimicrobial susceptibility for azithromycin and ceftriaxone in Neisseria gonorrhoeae isolates in Amsterdam, the Netherlands, between 2012 and 2015.
    Wind CM; Schim van der Loeff MF; van Dam AP; de Vries HJ; van der Helm JJ
    Euro Surveill; 2017 Jan; 22(1):. PubMed ID: 28079519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Committee Opinion No. 645: Dual Therapy for Gonococcal Infections.
    Obstet Gynecol; 2016 May; 127(5):e95-9. PubMed ID: 27548425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Should we still use azithromycin for gonorrhoea treatment?
    Mensforth S; Ross JDC
    Sex Health; 2019 Sep; 16(5):442-448. PubMed ID: 31207203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retreatment rates for uncomplicated gonorrhea infection: comparing ceftriaxone and azithromycin versus ceftriaxone and doxycycline.
    Schumacher CM; Ghanem KG
    Sex Transm Dis; 2013 Jul; 40(7):539-45. PubMed ID: 23965767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gonorrhoea treatment position statement.
    Fifer H; Hughes G; Radcliffe K
    Sex Transm Infect; 2015 Aug; 91(5):307. PubMed ID: 26195472
    [No Abstract]   [Full Text] [Related]  

  • 13. CDC update on gonorrhea: expand treatment to limit resistance.
    Campos-Outcalt D
    J Fam Pract; 2011 Dec; 60(12):736-40. PubMed ID: 22163356
    [No Abstract]   [Full Text] [Related]  

  • 14. In vitro efficacy of 21 dual antimicrobial combinations comprising novel and currently recommended combinations for treatment of drug resistant gonorrhoea in future era.
    Singh V; Bala M; Bhargava A; Kakran M; Bhatnagar R
    PLoS One; 2018; 13(3):e0193678. PubMed ID: 29509792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of in vitro synergy for dual antimicrobial therapy against resistant Neisseria gonorrhoeae using Etest and agar dilution.
    Wind CM; de Vries HJ; van Dam AP
    Int J Antimicrob Agents; 2015 Mar; 45(3):305-8. PubMed ID: 25532741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection in the United Kingdom of the
    Eyre DW; Town K; Street T; Barker L; Sanderson N; Cole MJ; Mohammed H; Pitt R; Gobin M; Irish C; Gardiner D; Sedgwick J; Beck C; Saunders J; Turbitt D; Cook C; Phin N; Nathan B; Horner P; Fifer H
    Euro Surveill; 2019 Mar; 24(10):. PubMed ID: 30862336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decline in Decreased Cephalosporin Susceptibility and Increase in Azithromycin Resistance in Neisseria gonorrhoeae, Canada.
    Martin I; Sawatzky P; Liu G; Allen V; Lefebvre B; Hoang L; Drews S; Horsman G; Wylie J; Haldane D; Garceau R; Ratnam S; Wong T; Archibald C; Mulvey MR
    Emerg Infect Dis; 2016 Jan; 22(1):65-7. PubMed ID: 26689114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retrospective analysis of antimicrobial susceptibility trends (2000-2009) in Neisseria gonorrhoeae isolates from countries in Latin America and the Caribbean shows evolving resistance to ciprofloxacin, azithromycin and decreased susceptibility to ceftriaxone.
    Starnino S; ; Galarza P; Carvallo ME; Benzaken AS; Ballesteros AM; Cruz OM; Hernandez AL; Carbajal JL; Borthagaray G; Payares D; Dillon JA
    Sex Transm Dis; 2012 Oct; 39(10):813-21. PubMed ID: 23001269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Non-viral sexually transmitted infections - Epidemiology, clinical manifestations, diagnostics and therapy : Part 1: Gonococci].
    Nenoff P; Manos A; Ehrhard I; Krüger C; Paasch U; Helmbold P; Handrick W
    Hautarzt; 2017 Jan; 68(1):43-49. PubMed ID: 27981386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gentamicin versus ceftriaxone for the treatment of gonorrhoea (G-TOG trial): study protocol for a randomised trial.
    Brittain C; Childs M; Duley L; Harding J; Hepburn T; Meakin G; Montgomery AA; Tan W; Ross JD
    Trials; 2016 Nov; 17(1):558. PubMed ID: 27881151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.